RecruitingACTRN12613000580774

The Maternal Pertussis Randomised Control Trial: best practice for the communication of pertussis booster vaccine recommendations to new mothers.

The influence of baseline attitudes, modifiable factors and health message framing on whooping cough booster vaccine uptake among new mothers on the postnatal ward.


Sponsor

Associate Professor John Sinn

Enrollment

1,080 participants

Start Date

Mar 26, 2012

Study Type

Interventional

Conditions

Summary

The cocooning strategy, which was implemented in Australia in 2009, can have a strong protective effect (indirect) against pertussis in infants. To achieve high maternal coverage, understanding maternal attitudes and other potentially influential factors is important. In this study, we examined the influence of baseline attitudes, modifiable factors and health message framing on pertussis booster vaccine uptake among postpartum women in the hospital setting.


Eligibility

Sex: FemalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at the best way for hospital staff to communicate with new mothers about getting a whooping cough (pertussis) booster vaccination. Whooping cough can be very dangerous for newborn babies, and one way to protect them is for parents to be vaccinated. The study is comparing different ways of presenting health information about the vaccine to see which approach leads to more mothers getting vaccinated before leaving the hospital after giving birth. You may be eligible if: - You are a woman who has recently given birth (postpartum) - You are not up to date with your pertussis booster (dTpa) vaccine (i.e., last received more than 10 years ago or never) - You are able to give written informed consent in English You may NOT be eligible if: - You require an interpreter to communicate - You are unable to give written informed consent Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Health-message framing: The tri-fold, coloured A4 pamphlet was written either in a gain or loss frame, indicating either what mothers gain from the cocooning strategy or what mothers would lose by not

Health-message framing: The tri-fold, coloured A4 pamphlet was written either in a gain or loss frame, indicating either what mothers gain from the cocooning strategy or what mothers would lose by not receiving the pertussis booster vaccine (for adults). The intervention was administered by the research nurse once the baseline questionnaire was completed. Allocation concealment was implement by placing the pamphlet in an opaque envelope. The interventions ( gain or loss pamphlet) were allocated to participants using random block allocation by week.


Locations(1)

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000580774


Related Trials